CDK7 and neoplasm: Additionally, a recent study has indicated that tumorigenesis can be effectively managed by targeting the CDK7-mediated CDK4/RB pathway and that FERM domain-containing 8 disrupts the interaction of CDK7 with CDK4, thereby inhibiting the activation of CDK4 to affect tumor growth [45].